Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems
Open Access
- 19 April 2022
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 22 (1) , 1-12
Abstract
Background: To evaluate the diagnostic performance of multiparametric transrectal ultrasound (TRUS) and to design diagnostic scoring systems based on four modes of TRUS to predict peripheral zone prostate cancer (PCa) and clinically significant prostate cancer (csPCa). Methods: A development cohort involved 124 nodules from 116 patients, and a validation cohort involved 72 nodules from 67 patients. Predictors for PCa and csPCa were extracted to construct PCa and csPCa models based on regression analysis of the development cohort. An external validation was performed to assess the performance of models using area under the curve (AUC). Then, PCa and csPCa diagnostic scoring systems were established to predict PCa and csPCa. The diagnostic accuracy was compared between PCa and csPCa scores and PI-RADS V2, using receiver operating characteristics (ROC) and decision curve analysis (DCA). Results: Regression models were established as follows: PCa = − 8.284 + 4.674 × Margin + 1.707 × Adler grade + 3.072 × Enhancement patterns + 2.544 × SR; csPCa = − 7.201 + 2.680 × Margin + 2.583 × Enhancement patterns + 2.194 × SR. The PCa score ranged from 0 to 6 points, and the csPCa score ranged from 0 to 3 points. A PCa score of 5 or higher and a csPCa score of 3 had the greatest diagnostic performance. In the validation cohort, the AUC for the PCa score and PI-RADS V2 in diagnosing PCa were 0.879 (95% confidence interval [CI] 0.790–0.967) and 0.873 (95%CI 0.778–0.969). For the diagnosis of csPCa, the AUC for the csPCa score and PI-RADS V2 were 0.806 (95%CI 0.700–0.912) and 0.829 (95%CI 0.727–0.931). Conclusions: The multiparametric TRUS diagnostic scoring systems permitted better identifications of peripheral zone PCa and csPCa, and their performances were comparable to that of PI-RADS V2.Keywords
Funding Information
- the Suzhou Municipal Science and Technology Bureau (SS201855, SS201855, SS201855, SS201855, SS201855, SS201855, SS201855, SS201855)
This publication has 23 references indexed in Scilit:
- Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology ValidationUltrasound in Medicine & Biology, 2016
- Multiparametric magnetic resonance imaging: Current role in prostate cancer managementInternational Journal of Urology, 2016
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2016
- Prostate cancer in East Asia: evolving trend over the last decadeAsian Journal of Andrology, 2015
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013European Urology, 2014
- Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient CareEuropean Urology, 2013
- Detection of prostate carcinoma with contrast‐enhanced sonography using intermittent harmonic imagingCancer, 2005
- Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimenProstate Cancer and Prostatic Diseases, 2001
- Initial Experience with Contrast-Enhanced Sonography of the ProstateAmerican Journal of Roentgenology, 2000
- The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancerUrology, 1997